Usana price target raised to $38 from $35 at DA Davidson

DA Davidson raised the firm’s price target on Usana (USNA) to $38 from $35 and keeps a Neutral rating on the shares following a transition of coverage. The firm estimates the company’s acquisition of a 78.8% controlling stake in Hiya Health for $205M is about 51c or 23% accretive to 2025 earnings per share. However, DA lowered its organic sales estimate to down 6% year-over-year for 2025 from down 1.5% “to be conservative.” The addition of Hiya is a “valuable strategic move,” but the core business continues to decline, the analyst tells investors in a research note.